| Year |
Citation |
Score |
| 2023 |
Devine JW, Lim D, Lugo A, Farley JF. Prevalence and patterns of catastrophic spending for antidiabetic medication in 2020. Journal of Managed Care & Specialty Pharmacy. 29: 1158-1164. PMID 37776114 DOI: 10.18553/jmcp.2023.29.10.1158 |
0.355 |
|
| 2022 |
Waghmare PH, Huang CY, Jaynes HA, Green WM, Snyder ME, Adeoye-Olatunde OA, Coe AB, Farley JF, Zillich AJ. Disparities in Medicare beneficiaries' receiving medication synchronization. Journal of the American Pharmacists Association : Japha. PMID 36463009 DOI: 10.1016/j.japh.2022.10.021 |
0.373 |
|
| 2022 |
Farris KB, Cadwallader T, Farley J, Gatwood K, Mackler E, Gatwood J. Implementation of a model integrating primary and oncology pharmacists' care for patients taking oral anticancer agents (OAA). Exploratory Research in Clinical and Social Pharmacy. 7: 100163. PMID 35957656 DOI: 10.1016/j.rcsop.2022.100163 |
0.353 |
|
| 2022 |
Rivers ZT, Parsons HM, Jacobson PA, Kuntz KM, Farley JF, Stenehjem DJ. Opportunities for personalizing colorectal cancer care: an analysis of SEER-medicare data. The Pharmacogenomics Journal. PMID 35361994 DOI: 10.1038/s41397-022-00276-6 |
0.326 |
|
| 2022 |
McDaniel CC, Chou C, Camp C, Hohmann NS, Hastings TJ, Maciejewski ML, Farley JF, Domino ME, Hansen RA. Primary Care Physicians', Psychiatrists', and Oncologists' Coordination While Prescribing Medications for Patients With Multiple Chronic Conditions. Journal of Patient Safety. 18: e424-e430. PMID 35188930 DOI: 10.1097/PTS.0000000000000838 |
0.333 |
|
| 2020 |
Chou C, McDaniel CC, Abrams JD, Farley JF, Hansen RA. An Examination of Prescribing Responsibilities between Psychiatrists and Primary Care Providers. The Psychiatric Quarterly. PMID 32829447 DOI: 10.1007/S11126-020-09828-0 |
0.423 |
|
| 2020 |
Spees LP, Wheeler SB, Zhou X, Amin KB, Baggett CD, Lund JL, Urick BY, Farley JF, Reeder-Hayes KE, Trogdon JG. Changes in chronic medication adherence, costs, and health care use after a cancer diagnosis among low-income patients and the role of patient-centered medical homes. Cancer. PMID 32780539 DOI: 10.1002/Cncr.33147 |
0.442 |
|
| 2020 |
Urick BY, Trygstad TK, Farley JF. Patient outcomes from implementing an enhanced services pharmacy network. Journal of the American Pharmacists Association : Japha. PMID 32680782 DOI: 10.1016/J.Japh.2020.05.009 |
0.353 |
|
| 2020 |
Blalock SJ, Renfro CP, Robinson JM, Farley JF, Busby-Whitehead J, Ferreri SP. Using the Drug Burden Index to identify older adults at highest risk for medication-related falls. Bmc Geriatrics. 20: 208. PMID 32532276 DOI: 10.1186/S12877-020-01598-5 |
0.41 |
|
| 2020 |
Urick BY, Bhosle M, Farley JF. Patient Medication Adherence Among Pharmacies Participating in a North Carolina Enhanced Services Network. Journal of Managed Care & Specialty Pharmacy. 26: 718-722. PMID 32463769 DOI: 10.18553/Jmcp.2020.26.6.718 |
0.376 |
|
| 2020 |
Grove LR, Domino ME, Farley JF, Swietek KE, Beadles C, Ellis AR, Jackson CT, DuBard CA. Medical home effects on enrollees with mental and physical illness. The American Journal of Managed Care. 26: 218-223. PMID 32436679 DOI: 10.37765/Ajmc.2020.43153 |
0.396 |
|
| 2020 |
Lund JL, Gupta P, Amin KB, Meng K, Urick BY, Reeder-Hayes KE, Farley JF, Wheeler SB, Spees L, Trogdon JG. Changes in chronic medication adherence in older adults with cancer versus matched cancer-free cohorts. Journal of Geriatric Oncology. PMID 32423699 DOI: 10.1016/J.Jgo.2020.04.012 |
0.37 |
|
| 2020 |
Blalock SJ, Ferreri SP, Renfro CP, Robinson JM, Farley JF, Ray N, Busby-Whitehead J. Impact of STEADI-Rx: A Community Pharmacy-Based Fall Prevention Intervention. Journal of the American Geriatrics Society. PMID 32315461 DOI: 10.1111/Jgs.16459 |
0.307 |
|
| 2020 |
Murugappan MN, Seifert RD, Farley JF. Examining Medicare Part D Medication Therapy Management program in the context of mental health. Journal of the American Pharmacists Association : Japha. PMID 31953120 DOI: 10.1016/J.Japh.2019.12.008 |
0.384 |
|
| 2020 |
Pestka DL, Zillich AJ, Coe AB, Farris KB, Adeoye OA, Snyder ME, Farley JF. Nationwide estimates of medication therapy management delivery under the Medicare prescription drug benefit. Journal of the American Pharmacists Association : Japha. PMID 31926872 DOI: 10.1016/J.Japh.2019.12.002 |
0.402 |
|
| 2019 |
Coe AB, Adeoye-Olatunde OA, Pestka DL, Snyder ME, Zillich AJ, Farris KB, Farley JF. Patterns and predictors of older adult Medicare Part D beneficiaries' receipt of medication therapy management. Research in Social & Administrative Pharmacy : Rsap. PMID 31859225 DOI: 10.1016/J.Sapharm.2019.12.007 |
0.421 |
|
| 2019 |
Chou C, Hohmann NS, Hastings TJ, Li C, McDaniel CC, Maciejewski ML, Farley JF, Domino ME, Hansen RA. How comfortable are primary care physicians and oncologists prescribing medications for comorbidities in patients with cancer? Research in Social & Administrative Pharmacy : Rsap. PMID 31734101 DOI: 10.1016/J.Sapharm.2019.11.006 |
0.356 |
|
| 2019 |
Farley JF, Kumar A, Urick BY. Measuring Adherence: A Proof of Concept Study for Multiple Medications for Chronic Conditions in Alternative Payment Models. Pharmacy (Basel, Switzerland). 7. PMID 31269735 DOI: 10.3390/pharmacy7030081 |
0.303 |
|
| 2019 |
Farley JF. Are the Benefits of Value-Based Insurance Design Conclusive? Journal of Managed Care & Specialty Pharmacy. 25: 736-738. PMID 31232204 DOI: 10.18553/Jmcp.2019.25.7.736 |
0.423 |
|
| 2019 |
Wang Y, Farley JF, Ferreri SP, Renfro CP. Do comprehensive medication review completion rates predict medication use and management quality? Research in Social & Administrative Pharmacy : Rsap. 15: 417-424. PMID 30917893 DOI: 10.1016/J.Sapharm.2018.06.010 |
0.434 |
|
| 2019 |
Spees L, Wheeler SB, Zhou X, Amin KB, Baggett C, Lund JL, Urick B, Farley J, Reeder-Hayes KE, Trogdon JG. The effect of medical home enrollment on cardiometabolic medication adherence among Medicaid-insured cancer patients. Journal of Clinical Oncology. 37: 279-279. DOI: 10.1200/Jco.2019.37.27_Suppl.279 |
0.438 |
|
| 2018 |
Swietek KE, Domino ME, Beadles C, Ellis AR, Farley JF, Grove LR, Jackson C, DuBard CA. Do Medical Homes Improve Quality of Care for Persons with Multiple Chronic Conditions? Health Services Research. PMID 30088272 DOI: 10.1111/1475-6773.13024 |
0.397 |
|
| 2018 |
Turner K, Trogdon JG, Weinberger M, Stover AM, Ferreri S, Farley JF, Ray N, Patti M, Renfro C, Shea CM. Testing the organizational theory of innovation implementation effectiveness in a community pharmacy medication management program: a hurdle regression analysis. Implementation Science : Is. 13: 105. PMID 30064454 DOI: 10.1186/S13012-018-0799-5 |
0.339 |
|
| 2018 |
Hansen RA, Hohmann N, Maciejewski ML, Domino ME, Ray N, Mahendraratnam N, Farley JF. Continuity of Medication Management among Adults with Schizophrenia and Comorbid Cardiometabolic Conditions. Journal of Pharmaceutical Health Services Research: An Official Journal of the Royal Pharmaceutical Society of Great Britain. 9: 13-20. PMID 29552104 DOI: 10.1111/Jphs.12201 |
0.39 |
|
| 2017 |
Olesiuk WJ, Farley JF, Domino ME, Ellis AR, Morrissey JP. Do Medical Homes Offer Improved Diabetes Care for Medicaid Enrollees with Co-occurring Schizophrenia? Journal of Health Care For the Poor and Underserved. 28: 1030-1041. PMID 28804075 DOI: 10.1353/Hpu.2017.0094 |
0.38 |
|
| 2017 |
Grove LR, Olesiuk WJ, Ellis AR, Lichstein JC, DuBard CA, Farley JF, Jackson CT, Beadles CA, Morrissey JP, Domino ME. Evaluating the potential for primary care to serve as a mental health home for people with schizophrenia. General Hospital Psychiatry. 47: 14-19. PMID 28779642 DOI: 10.1016/J.Genhosppsych.2017.03.002 |
0.317 |
|
| 2017 |
Farley JF, Ferreri SP, Easter JC, McClurg MR. The North Carolina Experiment: Active Research in the Development and Assessment of New Practice Models. North Carolina Medical Journal. 78: 186-190. PMID 28576958 DOI: 10.18043/Ncm.78.3.186 |
0.346 |
|
| 2017 |
Farley JF, Hansen RA, Domino ME, Borse M, Mahendraratnam N, Ray N, Maciejewski ML. Continuity of medication management in Medicaid patients with chronic comorbid conditions: An examination by mental health status. General Hospital Psychiatry. 45: 25-31. PMID 28274335 DOI: 10.1016/J.Genhosppsych.2016.12.001 |
0.371 |
|
| 2017 |
Mahendraratnam N, Dusetzina SB, Farley JF. Prescription Drug Utilization and Reimbursement Increased Following State Medicaid Expansion in 2014. Journal of Managed Care & Specialty Pharmacy. 23: 355-363. PMID 28230452 DOI: 10.18553/Jmcp.2017.23.3.355 |
0.431 |
|
| 2017 |
Amin K, Farley JF, Maciejewski ML, Domino ME. Effect of Medicaid Policy Changes on Medication Adherence: Differences by Baseline Adherence. Journal of Managed Care & Specialty Pharmacy. 23: 337-345. PMID 28230447 DOI: 10.18553/Jmcp.2017.23.3.337 |
0.409 |
|
| 2017 |
Smith MG, Shea CM, Brown P, Wines K, Farley JF, Ferreri SP. Pharmacy characteristics associated with the provision of medication management services within an integrated care management program. Journal of the American Pharmacists Association : Japha. PMID 28173992 DOI: 10.1016/J.Japh.2016.12.073 |
0.35 |
|
| 2016 |
Roberts AW, Farley JF, Holmes GM, Oramasionwu CU, Ringwalt C, Sleath B, Skinner AC. Controlled Substance Lock-In Programs: Examining An Unintended Consequence Of A Prescription Drug Abuse Policy. Health Affairs (Project Hope). 35: 1884-1892. PMID 27702963 DOI: 10.1377/Hlthaff.2016.0355 |
0.315 |
|
| 2015 |
Domino ME, Jackson C, Beadles CA, Lichstein JC, Ellis AR, Farley JF, Morrissey JP, DuBard CA. Do primary care medical homes facilitate care transitions after psychiatric discharge for patients with multiple chronic conditions? General Hospital Psychiatry. PMID 26725539 DOI: 10.1016/J.Genhosppsych.2015.11.002 |
0.401 |
|
| 2015 |
Beadles CA, Ellis AR, Lichstein JC, Farley JF, Jackson CT, Morrissey JP, Domino ME. First outpatient follow-up after psychiatric hospitalization: does one size fit all? Psychiatric Services (Washington, D.C.). 66: 364-72. PMID 25828981 DOI: 10.1176/Appi.Ps.201400081 |
0.313 |
|
| 2015 |
Hansen RA, Voils CI, Farley JF, Powers BJ, Sanders LL, Sleath B, Maciejewski ML. Prescriber continuity and medication adherence for complex patients. The Annals of Pharmacotherapy. 49: 293-302. PMID 25549627 DOI: 10.1177/1060028014563266 |
0.415 |
|
| 2015 |
Beadles CA, Farley JF, Ellis AR, Lichstein JC, Morrissey JP, DuBard CA, Domino ME. Do medical homes increase medication adherence for persons with multiple chronic conditions? Medical Care. 53: 168-76. PMID 25517069 DOI: 10.1097/Mlr.0000000000000292 |
0.424 |
|
| 2014 |
Beadles CA, Voils CI, Crowley MJ, Farley JF, Maciejewski ML. Continuity of medication management and continuity of care: Conceptual and operational considerations. Sage Open Medicine. 2: 2050312114559261. PMID 26770750 DOI: 10.1177/2050312114559261 |
0.423 |
|
| 2014 |
Zlott D, Farley JF, Guidotti M. Era of specialty pharmaceuticals expands opportunities for pharmacists. Journal of the American Pharmacists Association : Japha. 54: 578-80, 582. PMID 25379979 DOI: 10.1331/Japha.2014.14540 |
0.39 |
|
| 2014 |
Roberts AW, Crisp GD, Esserman DA, Roth MT, Weinberger M, Farley JF. Patterns of medication adherence and health care utilization among patients with chronic disease who were enrolled in a pharmacy assistance program. North Carolina Medical Journal. 75: 310-8. PMID 25237868 DOI: 10.18043/Ncm.75.5.310 |
0.441 |
|
| 2014 |
Crisp GD, Roberts AW, Esserman DA, Roth MT, Weinberger M, Farley JF. The University of North Carolina's Health Care Pharmacy Assistance Progam. North Carolina Medical Journal. 75: 303-9. PMID 25237867 DOI: 10.18043/Ncm.75.5.303 |
0.438 |
|
| 2014 |
Lauffenburger JC, Mayer CL, Hawke RL, Brouwer KL, Fried MW, Farley JF. Medication use and medical comorbidity in patients with chronic hepatitis C from a US commercial claims database: high utilization of drugs with interaction potential. European Journal of Gastroenterology & Hepatology. 26: 1073-82. PMID 25014625 DOI: 10.1097/Meg.0000000000000152 |
0.341 |
|
| 2014 |
Lichstein JC, Domino ME, Beadles CA, Ellis AR, Farley JF, Morrissey JP, Gauchat GW, Dubard CA, Jackson CT. Use of medical homes by patients with comorbid physical and severe mental illness. Medical Care. 52: S85-91. PMID 24561764 DOI: 10.1097/Mlr.0000000000000025 |
0.404 |
|
| 2014 |
Maciejewski ML, Wansink D, Lindquist JH, Parker JC, Farley JF. Value-based insurance design program in north Carolina increased medication adherence but was not cost neutral. Health Affairs (Project Hope). 33: 300-8. PMID 24493774 DOI: 10.1377/Hlthaff.2013.0260 |
0.477 |
|
| 2014 |
Maciejewski ML, Powers BJ, Sanders LL, Farley JF, Hansen RA, Sleath B, Voils CI. The intersection of patient complexity, prescriber continuity and acute care utilization. Journal of General Internal Medicine. 29: 594-601. PMID 24408277 DOI: 10.1007/S11606-013-2746-0 |
0.401 |
|
| 2014 |
Wang CC, Maciejewski ML, Rao JK, Sheitman BB, Sleath BL, Farley JF. Examining the relationship between adjunctive psychotherapy use and antipsychotic persistence and hospitalization. Administration and Policy in Mental Health. 41: 598-607. PMID 23733044 DOI: 10.1007/S10488-013-0503-7 |
0.32 |
|
| 2014 |
Bogart M, Farley J. Characteristics And Treatment Patterns Of Persistent Asthma In The United States: Results From The 2011 Medical Expenditure Panel Survey Value in Health. 17: A171. DOI: 10.1016/J.Jval.2014.03.999 |
0.358 |
|
| 2013 |
Daugherty JB, Maciejewski ML, Farley JF. The impact of manufacturer coupon use in the statin market. Journal of Managed Care Pharmacy : Jmcp. 19: 765-72. PMID 24156645 DOI: 10.18553/Jmcp.2013.19.9.765 |
0.438 |
|
| 2013 |
Hansen RA, Farley JF, Maciejewski ML, Ye X, Qian C, Powers B. Real-world utilization patterns and outcomes of colesevelam hcl in the ge electronic medical record. Bmc Endocrine Disorders. 13: 24. PMID 23866087 DOI: 10.1186/1472-6823-13-24 |
0.348 |
|
| 2013 |
Christian RB, Farley JF, Sheitman B, McKee JR, Wei D, Diamond J, Chrisman A, Barnhill LJ, Wegner L, Palmes G, Trygstad T, Pfeiffenberger T, Wegner SE, Best R, Sikich L. A+KIDS, a web-based antipsychotic registry for North Carolina youths: an alternative to prior authorization. Psychiatric Services (Washington, D.C.). 64: 893-900. PMID 23728296 DOI: 10.1176/Appi.Ps.002762012 |
0.317 |
|
| 2013 |
Lauffenburger JC, Balasubramanian A, Farley JF, Critchlow CW, O'Malley CD, Roth MT, Pate V, Brookhart MA. Completeness of prescription information in US commercial claims databases. Pharmacoepidemiology and Drug Safety. 22: 899-906. PMID 23696101 DOI: 10.1002/Pds.3458 |
0.36 |
|
| 2013 |
Wang CC, Wei D, Farley JF. Impact of monthly prescription cap on medication persistence among patients with hypertension, hyperlipidemia, or diabetes. Journal of Managed Care Pharmacy : Jmcp. 19: 258-68. PMID 23537460 DOI: 10.18553/Jmcp.2013.19.3.258 |
0.409 |
|
| 2013 |
Wu CH, Wang CC, Katz AJ, Farley J. National trends of psychotropic medication use among patients diagnosed with anxiety disorders: results from medical expenditure panel survey 2004-2009. Journal of Anxiety Disorders. 27: 163-70. PMID 23428605 DOI: 10.1016/J.Janxdis.2012.11.004 |
0.476 |
|
| 2013 |
Ellis AR, Dusetzina SB, Hansen RA, Gaynes BN, Farley JF, Stürmer T. Confounding control in a nonexperimental study of STAR*D data: logistic regression balanced covariates better than boosted CART. Annals of Epidemiology. 23: 204-9. PMID 23419508 DOI: 10.1016/J.Annepidem.2013.01.004 |
0.312 |
|
| 2013 |
Branham AR, Katz AJ, Moose JS, Ferreri SP, Farley JF, Marciniak MW. Retrospective analysis of estimated cost avoidance following pharmacist-provided medication therapy management services. Journal of Pharmacy Practice. 26: 420-7. PMID 23178415 DOI: 10.1177/0897190012465992 |
0.375 |
|
| 2013 |
Wang CC, Farley JF. Patterns and predictors of antipsychotic medication use among the U.S. population: findings from the Medical Expenditure Panel Survey. Research in Social & Administrative Pharmacy : Rsap. 9: 263-75. PMID 21272525 DOI: 10.1016/J.Sapharm.2009.07.001 |
0.421 |
|
| 2013 |
Wegner S, Trygstad T, Wegner L, Christian R, Farley J, McKee J, Pfeiffenberger T, Stiles A, Moran K, Sheitman B. 857 – Findings from an online drug monitoring and safety registry for children prescribed antipsychotics European Psychiatry. 28: 1. DOI: 10.1016/S0924-9338(13)76028-0 |
0.436 |
|
| 2012 |
Farley JF, Hansen RA, Yu-Isenberg KS, Maciejewski ML. Antipsychotic adherence and its correlation to health outcomes for chronic comorbid conditions. The Primary Care Companion For Cns Disorders. 14. PMID 23106028 DOI: 10.4088/Pcc.11M01324 |
0.401 |
|
| 2012 |
Dusetzina SB, Farley JF, Weinberger M, Gaynes BN, Sleath B, Hansen RA. Treatment use and costs among privately insured youths with diagnoses of bipolar disorder. Psychiatric Services (Washington, D.C.). 63: 1019-25. PMID 22855210 DOI: 10.1176/Appi.Ps.201100516 |
0.311 |
|
| 2012 |
Hansen RA, Maciejewski M, Yu-Isenberg K, Farley JF. Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs. Psychiatric Services (Washington, D.C.). 63: 920-8. PMID 22706887 DOI: 10.1176/Appi.Ps.201100328 |
0.45 |
|
| 2012 |
Farley JF, Wansink D, Lindquist JH, Parker JC, Maciejewski ML. Medication adherence changes following value-based insurance design. The American Journal of Managed Care. 18: 265-74. PMID 22694064 |
0.317 |
|
| 2012 |
Wu CH, Farley JF, Gaynes BN. The association between antidepressant dosage titration and medication adherence among patients with depression. Depression and Anxiety. 29: 506-14. PMID 22553149 DOI: 10.1002/Da.21952 |
0.387 |
|
| 2012 |
Katz AJ, Dusetzina SB, Farley JF, Ellis AR, Gaynes BN, Castillo WC, Stürmer T, Hansen RA. Distressing adverse events after antidepressant switch in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: influence of adverse events during initial treatment with citalopram on development of subsequent adverse events with an alternative antidepressant. Pharmacotherapy. 32: 234-43. PMID 22392456 DOI: 10.1002/J.1875-9114.2011.01020.X |
0.301 |
|
| 2012 |
Gaynes BN, Dusetzina SB, Ellis AR, Hansen RA, Farley JF, Miller WC, Stürmer T. Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D. Journal of Clinical Psychopharmacology. 32: 114-9. PMID 22198447 DOI: 10.1097/Jcp.0B013E31823F705D |
0.323 |
|
| 2012 |
Hansen RA, Dusetzina SB, Ellis AR, Stürmer T, Farley JF, Gaynes BN. Risk of adverse events in treatment-resistant depression: propensity-score-matched comparison of antidepressant augment and switch strategies. General Hospital Psychiatry. 34: 192-200. PMID 22079151 DOI: 10.1016/J.Genhosppsych.2011.10.001 |
0.306 |
|
| 2012 |
Wu C, Wang C, Katz A, Farley J. PMH12 National Trends of Psychotropic Medication Use among Patients Diagnosed with Anxiety Disorders: Results from the Medical Expenditure Panel Survey 2004-2009 Value in Health. 15: A83. DOI: 10.1016/J.Jval.2012.03.457 |
0.454 |
|
| 2012 |
Wu C, Farley JF, Gaynes BN. Evaluating the Association of Initial Benzodiazepine Use and Antidepressant Adherence among Adults with Anxiety Disorders Journal of Experimental & Clinical Medicine. 4: 338-344. DOI: 10.1016/J.Jecm.2012.10.007 |
0.33 |
|
| 2011 |
Dusetzina SB, Gaynes BN, Weinberger M, Farley JF, Sleath B, Hansen RA. Receipt of guideline-concordant pharmacotherapy among children with new diagnoses of bipolar disorder. Psychiatric Services (Washington, D.C.). 62: 1443-9. PMID 22193791 DOI: 10.1176/Appi.Ps.000452011 |
0.365 |
|
| 2011 |
Farley JF, Wang CC, Hansen RA, Voils CI, Maciejewski ML. Continuity of antipsychotic medication management for Medicaid patients with schizophrenia. Psychiatric Services (Washington, D.C.). 62: 747-52. PMID 21724787 DOI: 10.1176/Ps.62.7.Pss6207_0747 |
0.451 |
|
| 2011 |
Farley J, Hansen R, Yu-Isenberg K, Maciejewski M. PMH46 THE EFFECT OF ANTIPSYCHOTIC ADHERENCE ON ADHERENCE TO DIABETES, HYPERLIPIDEMIA, AND HYPERTENSION MEDICATIONS AND ASSOCIATED HEALTH SERVICE UTILIZATION Value in Health. 14: A194. DOI: 10.1016/J.Jval.2011.02.1070 |
0.403 |
|
| 2011 |
Wu C, Farley J. PMH10 THE INFLUENCE OF COMORBID ANXIETY ON MEDICATION USE AND SERVICE UTILIZATION AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER: RESULTS FROM A RETROSPECTIVE CLAIMS DATABASE Value in Health. 14: A187. DOI: 10.1016/J.Jval.2011.02.1034 |
0.362 |
|
| 2011 |
Wang C, Wei D, Farley J. DM3 IMPACT OF MONTHLY PRESCRIPTION CAP ON MEDICATION PERSISTENCY AMONG PATIENTS WITH DIABETES, HYPERTENSION, OR HYPERLIPIDEMIA Value in Health. 14: A3. DOI: 10.1016/J.Jval.2011.02.017 |
0.376 |
|
| 2010 |
Maciejewski ML, Farley JF, Parker J, Wansink D. Copayment reductions generate greater medication adherence in targeted patients. Health Affairs (Project Hope). 29: 2002-8. PMID 21041739 DOI: 10.1377/Hlthaff.2010.0571 |
0.437 |
|
| 2010 |
Hansen RA, Farley JF, Droege M, Maciejewski ML. A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005. Clinical Therapeutics. 32: 1308-19. PMID 20678679 DOI: 10.1016/J.Clinthera.2010.07.011 |
0.319 |
|
| 2010 |
Chen SY, Hansen RA, Gaynes BN, Farley JF, Morrissey JP, Maciejewski ML. Guideline-concordant antidepressant use among patients with major depressive disorder. General Hospital Psychiatry. 32: 360-7. PMID 20633739 DOI: 10.1016/J.Genhosppsych.2010.03.007 |
0.343 |
|
| 2010 |
Farley JF, Dusetzina SB. Medicaid prescription drug utilization and expenditures following Part D. Journal of Health Care For the Poor and Underserved. 21: 715-28. PMID 20453368 DOI: 10.1353/Hpu.0.0278 |
0.392 |
|
| 2010 |
Farley JF. Medicaid prescription cost containment and schizophrenia: a retrospective examination. Medical Care. 48: 440-7. PMID 20351586 DOI: 10.1097/Mlr.0B013E3181D502Bd |
0.378 |
|
| 2010 |
Domino ME, Farley JF. Economic grand rounds: did Medicare Part D improve access to medications? Psychiatric Services (Washington, D.C.). 61: 118-20. PMID 20123814 DOI: 10.1176/Ps.2010.61.2.118 |
0.459 |
|
| 2010 |
Maciejewski ML, Farley JF, Hansen RA, Wei D, Harman JS. Part D plan enrollment by uninsured medicare beneficiaries. Medical Care. 48: 183-6. PMID 20057332 DOI: 10.1097/Mlr.0B013E3181Bd4E0A |
0.4 |
|
| 2010 |
Chen SY, Hansen RA, Farley JF, Gaynes BN, Morrissey JP, Maciejewski ML. Follow-up visits by provider specialty for patients with major depressive disorder initiating antidepressant treatment. Psychiatric Services (Washington, D.C.). 61: 81-5. PMID 20044424 DOI: 10.1176/Ps.2010.61.1.81 |
0.367 |
|
| 2010 |
Farley JF. Containing cost despite the cost. Medical Care. 48: 1-3. PMID 19956078 DOI: 10.1097/Mlr.0B013E3181Caad9A |
0.421 |
|
| 2010 |
Domino ME, Farley JF. Did Medicare Part D Improve Access to Medications Psychiatric Services. 61: 118-120. DOI: 10.1176/Appi.Ps.61.2.118 |
0.459 |
|
| 2009 |
Farley JF, Blalock SJ. Trends and determinants of prescription medication use for treatment of osteoporosis. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 66: 1191-201. PMID 19535658 DOI: 10.2146/Ajhp080248 |
0.47 |
|
| 2009 |
Dorn SD, Farley JF, Hansen RA, Shah ND, Sandler RS. Direct-to-consumer and physician promotion of tegaserod correlated with physician visits, diagnoses, and prescriptions. Gastroenterology. 137: 518-24, 524.e1-2. PMID 19445943 DOI: 10.1053/J.Gastro.2009.05.005 |
0.33 |
|
| 2009 |
Hansen R, Farley J, Droege M, Maciejewski M. PDB10 A COMPARISON OF ECONOMIC OUTCOMES BETWEEN ADHERENT AND NONADHERENT PATIENTS TREATED WITH ORAL ANTIDIABETIC MEDICATIONS Value in Health. 12: A98. DOI: 10.1016/S1098-3015(10)73554-3 |
0.372 |
|
| 2009 |
Dorn SD, Farley JF, Hansen RA, Shah N, Sandler RS. 151 The Effect of Direct to Consumer Advertisement and Physician Promotion of Tegaserod (Zelnorm) On Physician Visits, Diagnoses, and Prescriptions for Irritable Bowel Syndrome and Constipation Gastroenterology. 136: A-29. DOI: 10.1016/S0016-5085(09)60134-7 |
0.32 |
|
| 2008 |
Farley JF, Cline RR, Schommer JC, Hadsall RS, Nyman JA. Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications. Clinical Therapeutics. 30: 1524-39; discussion . PMID 18803994 DOI: 10.1016/J.Clinthera.2008.08.009 |
0.725 |
|
| 2008 |
Farley JF, Blalock SJ, Cline RR. Effect of the women's health initiative on prescription anti-osteoporosis medication utilization. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 19: 1603-12. PMID 18373048 DOI: 10.1007/S00198-008-0607-1 |
0.723 |
|
| 2007 |
Farley JF, Devine JW, Hadsall RS. Professional implications of the expansion of pharmacy-based medical clinics. Journal of the American Pharmacists Association : Japha. 47: 410-4. PMID 17510039 DOI: 10.1331/Japha.2007.06093 |
0.414 |
|
| 2006 |
Devine JW, Cline RR, Farley JF. Follow-on biologics: competition in the biopharmaceutical marketplace. Journal of the American Pharmacists Association : Japha. 46: 193-201; quiz 202-4. PMID 16602229 DOI: 10.1331/154434506776180595 |
0.638 |
|
| 2006 |
Farley JF, Cline RR, Gupta K. Racial variations in antiresorptive medication use: results from the 2000 Medical Expenditure Panel Survey (MEPS). Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 17: 395-404. PMID 16314982 DOI: 10.1007/S00198-005-2027-9 |
0.761 |
|
| 2005 |
Devine JW, Farley JF, Hadsall RS. Patterns and predictors of prescription medication use in the management of headache: findings from the 2000 Medical Expenditure Panel Survey. Headache. 45: 1171-80. PMID 16178947 DOI: 10.1111/J.1526-4610.2005.00240.X |
0.466 |
|
| 2005 |
Cline RR, Farley JF, Hansen RA, Schommer JC. Osteoporosis beliefs and antiresorptive medication use. Maturitas. 50: 196-208. PMID 15734601 DOI: 10.1016/J.Maturitas.2004.05.004 |
0.705 |
|
| 2004 |
Farley JF, Cline RR, Hansen RA. Resorptive drug use among community-dwelling women in Minnesota. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 61: 1577-85. PMID 15372831 DOI: 10.1093/Ajhp/61.15.1577 |
0.683 |
|
| Show low-probability matches. |